HighTower Advisors
BSX icon

HighTower Advisors’s Boston Scientific BSX Stock Holding History

HighTower Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-200
Closed -$2K – 3363
2022
Q3 		$2K Buy
+200
New +$8.02K ﹤0.01% 3093

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

HighTower Advisors's BSX Position: Q2 2026 in Review

HighTower Advisors reduced its Boston Scientific (BSX) stake by 27% in Q2 2026, selling an estimated $3.07M and leaving 153,501 shares worth $6.55M. The position accounts for 0.01% of the portfolio, ranked #1108.

HighTower Advisors first reported a position in BSX in Q2 2013 and has held it in 46 quarters since. The position peaked at $19.3M in Q2 2025. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • HighTower Advisors held 153,501 shares of Boston Scientific worth $6.55M as of Q2 2026.
  • HighTower Advisors sold 56,467 Boston Scientific shares in Q2 2026, an estimated $3.07M.
  • Boston Scientific made up 0.01% of HighTower Advisors's portfolio in Q2 2026, its #1108 holding.
  • HighTower Advisors first reported a position in Boston Scientific in Q2 2013 and has held it in 46 quarters since.
  • HighTower Advisors's Boston Scientific position peaked at $19.3M in Q2 2025.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.